Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peter D. Caravan, Ph.D.

Co-Author

This page shows the publications co-authored by Peter Caravan and Kenneth Tanabe.
Connection Strength

3.103
  1. Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver. Cell Mol Gastroenterol Hepatol. 2022 Jan 28.
    View in: PubMed
    Score: 0.246
  2. Author Correction: Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis. Sci Rep. 2021 Sep 07; 11(1):18167.
    View in: PubMed
    Score: 0.239
  3. Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis. Sci Rep. 2021 03 17; 11(1):6105.
    View in: PubMed
    Score: 0.232
  4. Collagen-targeted molecular imaging in diffuse liver diseases. Abdom Radiol (NY). 2020 11; 45(11):3545-3556.
    View in: PubMed
    Score: 0.222
  5. Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis. Radiology. 2020 07; 296(1):67-75.
    View in: PubMed
    Score: 0.218
  6. Molecular Magnetic Resonance Imaging of Fibrin Deposition in the Liver as an Indicator of Tissue Injury and Inflammation. Invest Radiol. 2020 04; 55(4):209-216.
    View in: PubMed
    Score: 0.217
  7. CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver Fibrosis. Radiology. 2018 05; 287(2):581-589.
    View in: PubMed
    Score: 0.184
  8. Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesis. JCI Insight. 2017 Jun 02; 2(11).
    View in: PubMed
    Score: 0.178
  9. Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model. Hepatology. 2017 03; 65(3):1015-1025.
    View in: PubMed
    Score: 0.173
  10. T2 relaxation time is related to liver fibrosis severity. Quant Imaging Med Surg. 2016 Apr; 6(2):103-14.
    View in: PubMed
    Score: 0.164
  11. 3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model. J Hepatol. 2015 Sep; 63(3):689-96.
    View in: PubMed
    Score: 0.155
  12. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology. 2014 Apr; 59(4):1577-90.
    View in: PubMed
    Score: 0.142
  13. Molecular MRI of collagen to diagnose and stage liver fibrosis. J Hepatol. 2013 Nov; 59(5):992-8.
    View in: PubMed
    Score: 0.136
  14. Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models. J Hepatol. 2012 Sep; 57(3):549-55.
    View in: PubMed
    Score: 0.126
  15. Positron Emission Tomography/Magnetic Resonance Imaging Versus the Standard of Care Imaging in the Diagnosis of Peritoneal Carcinomatosis. Ann Surg. 2022 Feb 17.
    View in: PubMed
    Score: 0.062
  16. Molecular Magnetic Resonance Imaging of Liver Fibrosis and Fibrogenesis Is Not Altered by Inflammation. Invest Radiol. 2021 04 01; 56(4):244-251.
    View in: PubMed
    Score: 0.058
  17. Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI. Clin Cancer Res. 2020 09 15; 26(18):5007-5018.
    View in: PubMed
    Score: 0.055
  18. Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A. Invest Radiol. 2019 11; 54(11):697-703.
    View in: PubMed
    Score: 0.053
  19. Molecular Magnetic Resonance Imaging Using a Redox-Active Iron Complex. J Am Chem Soc. 2019 04 10; 141(14):5916-5925.
    View in: PubMed
    Score: 0.050
  20. The farnesoid X receptor agonist EDP-305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction. FASEB J. 2019 06; 33(6):7103-7112.
    View in: PubMed
    Score: 0.050
  21. Manganese-Based Contrast Agents for Magnetic Resonance Imaging of Liver Tumors: Structure-Activity Relationships and Lead Candidate Evaluation. J Med Chem. 2018 10 11; 61(19):8811-8824.
    View in: PubMed
    Score: 0.049
  22. Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. Dis Model Mech. 2018 07 30; 11(7).
    View in: PubMed
    Score: 0.048
  23. Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonist. Hepatol Commun. 2018 Jul; 2(7):821-835.
    View in: PubMed
    Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.